세계의 심장 발작 진단 시장 : 검사별, 최종 사용자별 - 예측(2025-2030년)

The Heart Attack Diagnostics Market was valued at USD 13.97 billion in 2023, expected to reach USD 14.96 billion in 2024, and is projected to grow at a CAGR of 7.68%, to USD 23.47 billion by 2030.

The heart attack diagnostics market encompasses a range of tools and technologies designed to rapidly and accurately identify myocardial infarctions. The scope of this sector includes diagnostic tests such as electrocardiograms, blood tests for cardiac biomarkers like troponins, and advanced imaging techniques. Its necessity stems from the urgent need for early and precise detection to improve patient outcomes and reduce mortality rates. Applications of these diagnostics span emergency room settings, routine check-ups for at-risk individuals, and continuous monitoring technologies. In terms of end-use scope, hospitals, clinics, and research institutes are the primary users, though there's a rising trend towards personal health monitoring devices in home healthcare settings.

Key growth factors include the increasing prevalence of cardiovascular diseases due to lifestyle changes, aging populations, and advancements in diagnostic technologies that offer faster results with higher accuracy. Emerging opportunities lie in the integration of artificial intelligence and machine learning to enhance diagnostic capabilities and the development of non-invasive and point-of-care testing solutions. Companies can capitalize on these opportunities by investing in R&D and forming strategic partnerships with technology firms to innovate faster.

However, market growth faces challenges such as the high cost of advanced diagnostic equipment, which can be a barrier in emerging markets, alongside stringent regulatory requirements that elongate product approval times. Limitations also arise from potential inaccuracies in diagnostic tests and dependence on healthcare infrastructure in low-resource settings.

Innovation can be pursued in creating portable, cost-effective devices suitable for both remote and urban areas, and improving AI algorithms for predictive diagnostics, which can aid in preventive healthcare. The market is highly competitive, with major players focusing on mergers and acquisitions to enhance their product offerings, indicating a dynamic environment ripe for growth. Overall, continued investment in technological advancement and meeting regulatory standards are essential to harness the full potential of the heart attack diagnostics market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Attack Diagnostics Market

The Heart Attack Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of cardiovascular disease among younger and adult generation
  • Rising consumer awareness for preventive health
  • Higher adoption of sedentary lifestyles
• Market Restraints
  • High cost of heart attack diagnostic equipments
• Market Opportunities
  • Innovations in medical imaging technology
  • Deployment of AI and ML in heart attack diagnostics
• Market Challenges
  • Lack of skilled and experienced professionals

Porter's Five Forces: A Strategic Tool for Navigating the Heart Attack Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Attack Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Attack Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Attack Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Attack Diagnostics Market

A detailed market share analysis in the Heart Attack Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Attack Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Attack Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Attack Diagnostics Market

A strategic analysis of the Heart Attack Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Attack Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., ACS Diagnostics Inc., Asahi Kasei Corporation, Bio-Rad Laboratories Inc., Bionet Co., Ltd., Boston Scientific Corporation, Canon Medical Systems Corporation, Danaher Corporation, F. Hoffmann La-Roche Ltd., FUJIFILM Holdings Corp., GE Healthcare Inc., Hill Rom Holdings Inc. by Baxter International Inc., Koninklijke Philips N.V., Nihon Kohden Corp., and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Heart Attack Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Test, market is studied across Blood Tests, Echocardiogram, and Electrocardiogram.
• Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostics Centers, and Hospital & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of cardiovascular disease among younger and adult generation
    • 5.1.1.2. Rising consumer awareness for preventive health
    • 5.1.1.3. Higher adoption of sedentary lifestyles
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of heart attack diagnostic equipments
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in medical imaging technology
    • 5.1.3.2. Deployment of AI and ML in heart attack diagnostics
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled and experienced professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Heart Attack Diagnostics Market, by Test

• 6.1. Introduction
• 6.2. Blood Tests
• 6.3. Echocardiogram
• 6.4. Electrocardiogram

7. Heart Attack Diagnostics Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Diagnostics Centers
• 7.4. Hospital & Clinics

8. Americas Heart Attack Diagnostics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Heart Attack Diagnostics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Heart Attack Diagnostics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories Inc.
• 2. ACS Diagnostics Inc.
• 3. Asahi Kasei Corporation
• 4. Bio-Rad Laboratories Inc.
• 5. Bionet Co., Ltd.
• 6. Boston Scientific Corporation
• 7. Canon Medical Systems Corporation
• 8. Danaher Corporation
• 9. F. Hoffmann La-Roche Ltd.
• 10. FUJIFILM Holdings Corp.
• 11. GE Healthcare Inc.
• 12. Hill Rom Holdings Inc. by Baxter International Inc.
• 13. Koninklijke Philips N.V.
• 14. Nihon Kohden Corp.
• 15. Siemens Healthineers AG